Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
30%
ALSO IN CANC
CANC
54
HOLDINGS
15%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.3% | 5.3% | 5.3% |
|
MERCK & CO. INC. | 3.6% | 3.9% | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 3.5% | 3.5% |
|
JOHNSON & JOHNSON | 5.0% | 3.1% | 3.1% |
|
ABBVIE INC | 8.9% | 2.9% | 2.9% |
MEDX Overweight Relative to CANC
|
ELI LILLY & CO | 12.9% |
 |
NOVARTIS AG-ADR | 6.7% |
|
ABBVIE INC | 6.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.3% |
|
IONIS PHARMACEUTICALS, INC. | 5.0% |
|
ALNYLAM PHARMACEUTICALS INC | 5.0% |
|
PFIZER INC | 3.3% |
 |
ALKERMES PLC | 3.3% |
|
CRISPR THERAPEUTICS AG | 2.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.8% |
MEDX Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.9% |
|
ASTRAZENECA PLC | -4.5% |
|
BRIDGEBIO PHARMA, INC. | -4.5% |
|
NOVARTIS AG | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
EXELIXIS INC | -3.3% |
|
COGENT BIOSCIENCES INC | -3.3% |
|
NUVALENT, INC. CLASS A | -3.2% |
|
CELCUITY INC. | -2.4% |